Allay Therapeutics
Latest round
- Series D
Last raised
- Jan 2025
Total raised
- $143M
Investors
- 13
About Allay Therapeutics
Based in the US, Allay Therapeutics, Inc.Allay Therapeutics, Inc. was founded in 2017 and is headquartered in San Jose, US. The company focuses on developing advanced pain management technologies.Allay Therapeutics specializes in advanced pain management solutions that emphasize localized treatment, providing prolonged relief for patients recovering from surgery or dealing with chronic pain. Their core technology aims to deliver targeted pain management over weeks, addressing significant challenges associated with pain relief methods.Allay Therapeutics generates revenue through a B2B model, collaborating with healthcare institutions and distributors to deliver their pain management technologies. These transactions typically consist of direct sales agreements, ensuring that healthcare facilities can purchase their technology for effective patient care. Further, Allay Therapeutics aims to launch new innovative products that improve pain management strategies, reflecting its commitment to advancing patient care.
Who invested in Allay Therapeutics
13 investors across 3 rounds
See all investors in Allay Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Allay Therapeutics
Who invested in Allay Therapeutics?
Allay Therapeutics has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allay Therapeutics raised?
Allay Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Allay Therapeutics last raise money?
Allay Therapeutics's most recent round on record is a Series D, in Jan 2025.
What does Allay Therapeutics do?
Based in the US, Allay Therapeutics, Inc.
Where is Allay Therapeutics headquartered?
Allay Therapeutics is headquartered in San Jose, US.
Which VCs invest in companies like Allay Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Allay Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Allay Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.